January 10, 2014
Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has landed a $20 million round of investment that includes contributions from Merck Global Health Innovation Fund and Windham Venture Partners. The announcement marks WellDoc's first round of institutional money -- the company has long relied on angel investors and debt...
August 23, 2012
The U.S. spent $1.3 trillion in 2003 treating people with at least one chronic disease, according to a study in Health Affairs, and the price tag is projected to rise to $4.3 trillion by 2023. Chronic diseases account for about three-quarters of all healthcare spending in this country now, and that number won't be going down anytime soon if we continue on the current trajectory.
You haven't read...
August 21, 2012
According to a report in The New York Times this week, two as yet unnamed insurance companies have already agreed to pay more than $100 a month for patients who use WellDoc's DiabetesManager. The reimbursement will not begin until some time early next year, according to the newspaper. The report cites an interview with WellDoc president Anand Iyer as its source.
MobiHealthNews reported late last...
August 15, 2012
Waltham, Massachusetts-based Alere acquired wireless remote patient monitoring company MedApps last month for an undisclosed sum, MobiHealthNews has learned. MedApps CEO Kent Dicks confirmed the news in an email to MobiHealthNews this afternoon.
MedApps offers a suite of home health devices, including the HealthPAL, a small, portable, dedicated device that the company used to collect data from...
August 9, 2012
Alere has inked a deal with AT&T to market WellDoc's DiabetesManager mobile health program to health plans to offer disease management programs as well as to corporate payers. WellDoc and AT&T began co-marketing DiabetesManager in October 2010.
DiabetesManager is a mobile-enabled diabetes management application and service that helps adults with type 2 diabetes to better self-manage their...
May 2, 2012
In recent years Apple stores began selling fitness devices other than those offered by long time partner Nike+. The company also added Withings' WiFi-enabled scale to its store shelves. Soon followed iHealth's iOS Blood Pressure Monitor dock and more. This week Cupertino's retail stores have begun selling Sanofi's iBGStar device, the first FDA cleared iPhone-enabled blood glucose meter....
April 16, 2012
Allscripts' recently launched Wand EHR iPad app
In late 2010 MobiHealthNews reported on one of the first announced integrations of data from a patient-facing mobile health application and an electronic medical record in use at a healthcare facility: WellDoc integrated its DiabetesManager program with Allscripts' EHR because that happened to be the system in use at WellDoc's partner site, George...
January 12, 2012
Ford Motor Co. is building on its in-car health monitoring initiative by teaming with Microsoft and Healthrageous to research how people can monitor their health and promote wellness with connected devices while in their vehicles. The companies are taking advantage of the spotlight at the massive 2012 International CES trade show in Las Vegas this week to show off a prototype called "the car that...
September 22, 2011
Like any rapidly evolving industry, mobile health is suffering some growing pains.
A study published in the September issue of the journal Diabetes Care found that type 2 diabetes patients who were given behavioral coaching with the mobile phone-based WellDoc DiabetesManager system lowered their hemoglobin A1c readings significantly more than those who only received care during occasional doctor...
August 1, 2011
WellDoc released this week the pre-print version of the first randomized controlled trial (RCT) study using a mHealth solution (WellDoc's DiabetesManager) to track reduction in blood glucose levels over one year compared against usual methods. According to the study results, "the mean decline in A1C (the gold-standard measure for diabetes control) was 1.9% in the intervention group and 0.7% in...